U.S. House · 118th Congress · H.R. 1825
Right to Try Clarification Act
To clarify that the Federal Right to Try law applies to schedule I substances for which a phase I clinical trial has been completed and to provide access for eligible patients to such substances pursuant to the Federal Right to Try law.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Earl BlumenauerD-OR-3
- Introduced
- March 28, 2023, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (4)
2 Democrats, 2 Republicans. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Andy BiggsR-AZ-5
- J. Luis CorreaD-CA-46
- Madeleine DeanD-PA-4
- Nancy MaceR-SC-1